Role of HMGB1 as a Suitable Biomarker of Subclinical Intestinal Inflammation and Mucosal Healing in Patients with Inflammatory Bowel Disease

Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn’s Disease

(2013) Guillaume Bouguen et al.   Clinical Gastroenterology and Hepatology

Definition and evaluation of mucosal healing in clinical practice

(2013) Silvia Mazzuoli et al.   DIGESTIVE AND LIVER DISEASE

Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin

(2013) Taina Sipponen   DIGESTIVE DISEASES

Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring

(2013) Jose-Manuel Benitez et al.   GUT

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

(2013) Laurent Peyrin-Biroulet et al.   GUT

Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study

(2013) Dinny Wallis et al.   ARTHRITIS RESEARCH & THERAPY

Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease

(2012) Fleur Schaper et al.   CURRENT OPINION IN RHEUMATOLOGY

Fecal Markers: Calprotectin and Lactoferrin

(2012) Bincy P. Abraham et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Endoscopic Assessment of Inflammatory Bowel Disease: Colonoscopy/Esophagogastroduodenoscopy

(2012) Grace Chan et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Mucosal healing in inflammatory bowel diseases: a systematic review

(2012) Markus F Neurath et al.   GUT

Danger Signals Activating the Immune Response after Trauma

(2012) Stefanie Hirsiger et al.   MEDIATORS OF INFLAMMATION

HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease

(2012) Helena Erlandsson Harris et al.   Nature Reviews Rheumatology

Inflammation and colorectal cancer: colitis-associated neoplasia

(2012) Sergei I. Grivennikov   Seminars in Immunopathology

Fecal HMGB1 Is a Novel Marker of Intestinal Mucosal Inflammation in Pediatric Inflammatory Bowel Disease

(2011) Roberta Vitali et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications

(2011) Ravichandran Ramasamy et al.   Annals of the New York Academy of Sciences

The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease

(2011) James D. Lewis   GASTROENTEROLOGY

Intestinal Inflammation and Cancer

(2011) Thomas A. Ullman et al.   GASTROENTEROLOGY

Endoscopic evaluation of Crohnʼs disease activity

(2010) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

(2010) Gert Van Assche et al.   Journal of Crohns & Colitis

Role of endoscopy in predicting the disease course in inflammatory bowel disease

(2010) Matthieu Allez   WORLD JOURNAL OF GASTROENTEROLOGY

Biological markers in inflammatory bowel disease: Practical consideration for clinicians

(2009) J.L. Mendoza et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

Biological Therapies for Inflammatory Bowel Diseases

(2009) Paul Rutgeerts et al.   GASTROENTEROLOGY

Novel Diagnostic and Prognostic Modalities in Inflammatory Bowel Disease

(2009) Timothy L. Zisman et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage

(2009) D Foell et al.   GUT

Clinical implications of mucosal healing for the management of IBD

(2009) Guillaume Pineton de Chambrun et al.   Nature Reviews Gastroenterology & Hepatology